PUBLISHER: Grand View Research | PRODUCT CODE: 1552598
PUBLISHER: Grand View Research | PRODUCT CODE: 1552598
U.S. Varicose Vein Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation/ Stripping), And Segment Forecasts, 2024 - 2030
U.S. Varicose Vein Treatment Devices Market Growth & Trends:
The U.S. varicose vein treatment devices market size is expected to reach USD 795.1 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as obesity, pregnancy, sedentary lifestyle, and physical activities like standing for longer durations is expected to drive the market growth.
The prevalence of vein diseases is high in population above 60 years at 26%, owing to the factors such as increasing age and development of conditions like hypertension and venous thrombosis. The incidence is lowest in the age group of 0 to 17 at 17% and is majorly due to the risk factors such as genetics, obesity, and lifestyle-related disorders affecting the arteries and veins.
Increasing technological advancements due to continuous R&D activities are anticipated to drive the market for varicose vein treatment devices. Many ongoing clinical trials conducted by the key market players study the use of novel systems over traditional treatment methods to gain a competitive edge over the existing devices. This increases competition in the market enhancing the quality of products introduced in the market. For instance, in June 2019, the Lake Washington Vascular Centre conducted a study based on patients with symptomatic varicose veins treated with Venaseal and Endovenous Thermal Ablation.
The total expenditure of Americans on combined surgical and nonsurgical cosmetic procedures was USD 13.5 billion in 2015. The percentage of nonsurgical procedures has grown by 44% since 2011 and accounted for 42% of the total expenditure done on cosmetic procedures. These statistics highlight that the market for varicose vein treatment devices is attractive for cosmetics purposes.
U.S. Varicose Vein Treatment Devices Market Report Highlights:
- Based on type, sclerotherapy accounted for the largest market share in 2023
- Medicare offers insurance for sclerotherapy procedures for varicose veins, resulting in its high adoption by the healthcare providers and patients
- Some of the key players operating in the U.S. varicose vein treatment devices market are Medtronic plc; AngioDynamics, Inc.; Biolitec AG; Lumenis Ltd.; Syneron Medical Ltd.; Energist Group; Eufoton srl; Quanta Systems S.p.A.; and Teleflex, Inc.
- In February 2015, Medtronic (then Covidien) received a pre-market approval from the U.S. Food and Drug Administration (FDA) for their new product, VenaSeal closure system-a minimally invasive and uses a medical adhesive to close the damaged vein in patients with vein diseases
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Type Segment
- 1.2. Estimates and Forecast Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Primary Research
- 1.5. Information or Data Analysis:
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.8. List of Secondary Sources
- 1.9. List of Abbreviations
- 1.10. Objective
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing preference for minimally invasive treatment procedures
- 3.2.1.2. Introduction of technologically advanced devices
- 3.2.1.3. Increasing geriatric population
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High procedural costs and inconsistent reimbursement structure
- 3.2.2.2. Risk factors associated with varicose veins treatment
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
Chapter 4. Type Business Analysis
- 4.1. Type Segment Dashboard
- 4.2. U.S. Varicose Vein Treatment Devices Market Type Movement Analysis
- 4.3. U.S. Varicose Vein Treatment Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Endovenous Ablation
- 4.4.1. Endovenous ablation market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Endovenous laser therapy
- 4.4.2.1. Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Radiofrequency ablation
- 4.4.3.1. Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Sclerotherapy
- 4.5.1. Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6. Surgical Ligation/Stripping
- 4.6.1. Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Competitive Landscape
- 5.1. Company Categorization
- 5.2. Strategy Mapping
- 5.3. Company Market Position Analysis, 2023
- 5.4. Company Profiles/Listing
- 5.4.1. Medtronic
- 5.4.1.1. Overview
- 5.4.1.2. Financial Performance
- 5.4.1.3. Product Benchmarking
- 5.4.1.4. Strategic Initiatives
- 5.4.2. AngioDynamics
- 5.4.2.1. Overview
- 5.4.2.2. Product Benchmarking
- 5.4.2.3. Strategic Initiatives
- 5.4.3. Candela Corporation
- 5.4.3.1. Overview
- 5.4.3.2. Financial Performance
- 5.4.3.3. Product Benchmarking
- 5.4.3.4. Strategic Initiatives
- 5.4.4. Lumenis Be Ltd.
- 5.4.4.1. Overview
- 5.4.4.2. Product Benchmarking
- 5.4.4.3. Strategic Initiatives
- 5.4.5. biolitec Holding GmbH & Co KG
- 5.4.5.1. Overview
- 5.4.5.2. Product Benchmarking
- 5.4.5.3. Strategic Initiatives
- 5.4.6. Eufoton s.r.l.
- 5.4.6.1. Overview
- 5.4.6.2. Financial Performance
- 5.4.6.3. Product Benchmarking
- 5.4.6.4. Strategic Initiatives
- 5.4.7. Energist
- 5.4.7.1. Overview
- 5.4.7.2. Financial Performance
- 5.4.7.3. Product Benchmarking
- 5.4.7.4. Strategic Initiatives
- 5.4.8. Teleflex Incorporated
- 5.4.8.1. Overview
- 5.4.8.2. Financial Performance
- 5.4.8.3. Product Benchmarking
- 5.4.8.4. Strategic initiatives
- 5.4.1. Medtronic
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviation
- Table 3 U.S. varicose vein treatment devices market, by type, 2018 - 2030 (USD Million)
- Table 4 Key companies undergoing expansions.
- Table 5 Key companies undergoing acquisitions.
- Table 6 Key companies undergoing collaborations.
- Table 7 Key companies launching new products/services.
- Table 8 Key companies undertaking other strategies
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Market formulation & validation
- Fig. 6 U.S. varicose vein treatment devices market: market outlook
- Fig. 7 U.S. varicose vein treatment devices competitive insights
- Fig. 8 Parent market outlook
- Fig. 9 U.S. varicose vein treatment devices market driver impact
- Fig. 10 U.S. varicose vein treatment devices market restraint impact: Type movement analysis
- Fig. 11 U.S. varicose vein treatment devices market: Type outlook and key takeaways
- Fig. 12 Endovenous Ablation market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 13 Endovenous laser therapy market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 14 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 15 Sclerotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 16 Surgical Ligation/Stripping market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 17 Market share of key market players - U.S. varicose vein treatment devices market
